Greece · Delayed Price · Currency is EUR Unibios Holdings Statistics
Total Valuation
ATH:BIOSK has a market cap or net worth of EUR 52.32 million. The enterprise value is 53.85 million.
| Market Cap | 52.32M |
| Enterprise Value | 53.85M |
Important Dates
The next estimated earnings date is Tuesday, December 30, 2025.
| Earnings Date | Dec 30, 2025 |
| Ex-Dividend Date | Oct 9, 2025 |
Share Statistics
ATH:BIOSK has 16.88 million shares outstanding. The number of shares has increased by 14.83% in one year.
| Current Share Class | 16.88M |
| Shares Outstanding | 16.88M |
| Shares Change (YoY) | +14.83% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 22.29.
| PE Ratio | 22.29 |
| Forward PE | n/a |
| PS Ratio | 3.42 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 102.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.20, with an EV/FCF ratio of -165.57.
| EV / Earnings | 22.52 |
| EV / Sales | 3.52 |
| EV / EBITDA | 18.20 |
| EV / EBIT | 21.40 |
| EV / FCF | -165.57 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.19 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | -21.35 |
| Interest Coverage | 6.41 |
Financial Efficiency
Return on equity (ROE) is 13.48% and return on invested capital (ROIC) is 6.68%.
| Return on Equity (ROE) | 13.48% |
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | 6.68% |
| Return on Capital Employed (ROCE) | 11.68% |
| Revenue Per Employee | 184,412 |
| Profits Per Employee | 28,807 |
| Employee Count | 79 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, ATH:BIOSK has paid 855,250 in taxes.
| Income Tax | 855,250 |
| Effective Tax Rate | 26.35% |
Stock Price Statistics
The stock price has increased by +106.67% in the last 52 weeks. The beta is 0.55, so ATH:BIOSK's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +106.67% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.15 |
| Relative Strength Index (RSI) | 64.74 |
| Average Volume (20 Days) | 39,984 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATH:BIOSK had revenue of EUR 15.31 million and earned 2.39 million in profits. Earnings per share was 0.14.
| Revenue | 15.31M |
| Gross Profit | 6.12M |
| Operating Income | 2.52M |
| Pretax Income | 3.25M |
| Net Income | 2.39M |
| EBITDA | 2.83M |
| EBIT | 2.52M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 5.42 million in cash and 6.94 million in debt, giving a net cash position of -1.52 million or -0.09 per share.
| Cash & Cash Equivalents | 5.42M |
| Total Debt | 6.94M |
| Net Cash | -1.52M |
| Net Cash Per Share | -0.09 |
| Equity (Book Value) | 18.84M |
| Book Value Per Share | 1.12 |
| Working Capital | 10.17M |
Cash Flow
In the last 12 months, operating cash flow was 510,516 and capital expenditures -835,731, giving a free cash flow of -325,215.
| Operating Cash Flow | 510,516 |
| Capital Expenditures | -835,731 |
| Free Cash Flow | -325,215 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 39.96%, with operating and profit margins of 16.44% and 15.62%.
| Gross Margin | 39.96% |
| Operating Margin | 16.44% |
| Pretax Margin | 21.21% |
| Profit Margin | 15.62% |
| EBITDA Margin | 18.46% |
| EBIT Margin | 16.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.65%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 0.65% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -14.83% |
| Shareholder Yield | -14.19% |
| Earnings Yield | 4.57% |
| FCF Yield | -0.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Feb 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ATH:BIOSK has an Altman Z-Score of 3.02 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.02 |
| Piotroski F-Score | 7 |